FDA Calendar: 2H09 Binary Event Trades – BioMedReports.com
July 26th, 2009
| Tags: agency, biomedreports, bla, calendar, class-ii-review, crl, fda, fda-calendar, Lung Cancer, nda, pdufa, phase, Pneumonia, priority-review, Stroke
On 5/28/09, Poniard Pharma (NASDAQ:PARD) announced updated clinical data from its randomized , controlled Phase 2 trial of picoplatin in patients with metastatic colorectal cancer (CRC). The new data demonstrated that picoplatin, …
See the original post here:
FDA Calendar: 2H09 Binary Event Trades – BioMedReports.com
Leave a comment
| Trackback